Cargando…
Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
The dichotomic nature of the adaptive immune response governs the outcome of clinical gene therapy. On the one hand, neutralizing antibodies and cytotoxic T cells can have a dramatic impact on the efficacy and safety of human gene therapies. On the other hand, regulatory T cells (Treg) can promote t...
Autores principales: | Wagner, Dimitrios Laurin, Peter, Lena, Schmueck-Henneresse, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455332/ https://www.ncbi.nlm.nih.gov/pubmed/33574580 http://dx.doi.org/10.1038/s41434-021-00232-2 |
Ejemplares similares
-
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021) -
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
por: Wendering, Desiree J., et al.
Publicado: (2019) -
Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
por: Amini, Leila, et al.
Publicado: (2021) -
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
por: Roemhild, Andy, et al.
Publicado: (2020) -
Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)